NCT05034146View on ClinicalTrials.gov

68Ga-FAPI PET/CT in Malignant Tumors

NARecruitingINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Fibroblast Activation Protein InhibitorPET/CTMalignant Neoplasm
Interventions
DRUG

68Ga-FAPI

68Ga-FAPI was injected intravenously to each subject, and the dose is calculated according to body weight of subject (approximately 1.85-3.7MBq/kg).

DEVICE

PET/CT

68Ga-FAPI PET/CT scan were performed 20\~60 min after 68Ga-FAPI (1.85-3.7MBq/kg) injection intravenously.

Trial Locations (1)

430071

RECRUITING

Zhongnan Hospital of Wuhan University, Wuhan

All Listed Sponsors
lead

Zhongnan Hospital

OTHER